Skip to main content
. 2020 Apr 10;39(7):2055–2062. doi: 10.1007/s10067-020-05073-9

Fig. 1.

Fig. 1

Potential therapeutic targets for SARS-CoV-2 and COVID-19. AAK1–AP2-associated protein kinase 1; ACE–angiotensin-converting enzyme; ARB–angiotensin receptor blocker; COVID-19–coronavirus disease 19; CQ–chloroquine; HCQ–hydroxychloroquine; IL–interleukin; JAK–Janus kinase; SARS-CoV-2–severe acute respiratory syndrome coronavirus 2; TLR–toll-like receptor; TMPRSS2–serine protease enzyme